Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Humana gets a rare stock upgrade at Wall Street amid recent woes

Published 10/08/2024, 10:34 AM
HUM
-

Investing.com -- Humana Inc (NYSE:HUM). received a notable upgrade from Bernstein analysts on Tuesday, with the firm moving its rating for the stock from Market-Perform to Outperform, despite the company's recent challenges.

The analysts are now optimistic about Humana's prospects, citing several factors that contribute to a more favorable outlook.

According to Bernstein, the upgrade is based on "a view that risks are being incorporated into expectations and price," as well as an "improved sector outlook and potential upside catalysts."

They believe that Humana's operating outlook for Medicare Advantage (MA) has improved, and uncertainties regarding risks such as STARS ratings and repricing execution are becoming clearer.

Bernstein noted that the stock has been "reduced" in price, enhancing the balance of upside risks compared to downside risks, including potential takeover interest and Pharmacy Benefit Manager (PBM) outsourcing.

However, Bernstein has adjusted its financial model in light of Humana's recent announcement regarding a significant decline in STARS ratings.

The analysts expect "decreased STARS ratings for 2026," estimating that around 25% of members will be in four-plus star plans.

While this will have a negative impact on earnings, Bernstein anticipates that pricing adjustments and member migration efforts could mitigate about two-thirds of the Medical Loss Ratio (MLR) impact. Consequently, they forecast a roughly 24% decline in adjusted earnings per share (EPS) for FY26.

As a result of these changes, Bernstein has lowered its price target for Humana to $308 from a previous $405. They have also reduced their target multiple to 16.0x next-twelve-month EPS, down from 18.0x, reflecting a delay in earnings recovery due to the STARS ratings issue.

Despite these challenges, the analysts' upgrade signifies a cautious optimism about Humana's potential moving forward.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.